Inquire Before Buying - Cancer Immunotherapy Market Size, Analysis & Growth Report

Global Cancer Immunotherapy Market Research Report: Forecast (2025-2030)

Cancer Immunotherapy Market Size - By Product Type Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies and Cancer Vaccines, Checkpoint Inhibitors, Others, By Cancer......Type Lung Cancer, Prostate Cancer, Breast Cancer, Ovarian Cancer, Pancreatic Cancer, Head and Neck Cancer, Melanoma, Colorectal Cancer, By Mechanism of Actions Active Immunotherapy, Passive Immunotherapy, By End Users Hospitals, Cancer Research Centers, Clinics) and Others Read more

Healthcare
Mar 2025
Pages 185
Report Format: PDF, Excel, PPT

Market Definition

Immunotherapy is a medical procedure that makes use of specific immune system components to treat conditions like cancer. It strengthens the body's built-in defenses against the disease. It uses compounds created by the body or in a lab to strengthen the immune system in order to locate and eliminate cancer cells. Cancer immunotherapy is used to treat a variety of malignancies including melanoma, prostate, breast, colorectal, lung, head & neck and more.

Market Insights & Analysis: Global Cancer Immunotherapy Market (2025-30)

The Global Cancer Immunotherapy Market size was valued at around USD 134.4 billion in 2024 and is projected to reach USD 214.7 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 8.12% during the forecast period, i.e., 2025-30.. The market is projected to experience significant growth due to several factors. One of the primary drivers is the increasing adoption of targeted therapy over traditional therapy, which has led to the emergence of biosimilars and increased demand for monoclonal antibodies (mAbs). The high prevalence of cancer also contributes to the rising inclination for such therapy, as immunotherapy drugs alter or boost the body's natural immune response to fight cancer. In conjugation, different immunotherapies, including CAR T-cell therapy, cancer vaccines, and immunomodulators, can be combined with other cancer treatments to achieve the best outcomes.

Report Coverage	Details
Historical Years	2020–23
Forecast Years	2025–30
Market Value in 2024	USD 134.4 Billion
Market Value by 2030	USD 214.7 Billion
CAGR (2025–30)	8.12%
Leading Region	North America
Top Key Players	Amgen Inc., Astrazeneca, Bayer AG, Bristol-Myers Squibb, ELI Lilly and Company, Janssen Global Services LLC, Johnson and Johnson, Merck, Novartis, Pfizer, F., Hoffmann-La Roche Ltd.
Segmentation	By Product Type Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies and Cancer Vaccines, Checkpoint Inhibitors, Others, By Cancer Type Lung Cancer, Prostate Cancer,...Breast Cancer, Ovarian Cancer, Pancreatic Cancer, Head and Neck Cancer, Melanoma, Colorectal Cancer, By Mechanism of Actions Active Immunotherapy, Passive Immunotherapy, By End Users Hospitals, Cancer Research Centers, Clinics) and others
Key Report Highlights	Market Dimensions & Projections Pricing Evaluation Recent Strategic Moves by Companies Primary Stakeholders Import/Export Trend Analysis Competitive Landscape Assessment Emerging Opportunities Market Trends and Indicators

*Boost strategic growth with in-depth market analysis - Get a free sample preview today!

In fact, immunotherapy has proven to be a more targeted treatment than conventional therapies such as radiation & chemotherapy, helping to avoid potential damage to healthy tissue, which is usually common in these therapies. Furthermore, with promising response rates and the potential for durable responses, the success achieved by cancer immunotherapy is notably higher and likely to impact cancer patients positively, therefore aiding in enhancing the Global Cancer Immunotherapy Market size. Perhaps it is why the demand for such treatment methods is augmenting among cancer patients across the globe. Above all, the global market shall also expand due to the ongoing research & new approvals for such treatment methods. Thus, backed by these aspects, the market is projected to witness a substantial surge in its revenue in the coming years.

Global Cancer Immunotherapy Market Driver:

Increasing Frequency of Approvals Received by Novel Immunotherapies - Increasing acceptance of novel immunotherapies is expected to bode well for market expansion in the coming years. For instance, The U.S. FDA authorized a number of anti-PD-1/L1 antibodies between 2020 and 2022 for the treatment of NSCLC, renal cell carcinoma, melanoma, breast, prostate, and other malignancies. These antibodies include nivolumab, atezolizumab, avelumab, dostarlimab, and others. Therefore, the increased approval of immunotherapeutic drugs has fueled market development in the past few years.

Research Basics
1. Product Definition
2. Research Process
3. Assumptions

Executive Summary
Expert Verbatim- What our Experts Say?
Global Cancer Immunotherapy Market Analysis, 2020- 2030F
1. Market Size & Analysis
  1. Market Revenue
2. Market Share & Analysis
  1. By Product Type
    1. Monoclonal Antibodies
    2. Immunomodulators
    3. Oncolytic Viral Therapies and Cancer Vaccines
    4. Checkpoint Inhibitors
    5. Others
  2. By Cancer Type
    1. Lung Cancer
    2. Prostate Cancer
    3. Breast Cancer
    4. Ovarian Cancer
    5. Pancreatic Cancer
    6. Head and Neck Cancer
    7. Melanoma
    8. Colorectal Cancer
  3. By Mechanism of Actions
    1. Active Immunotherapy
    2. Passive Immunotherapy
  4. By End Users
    1. Hospitals
    2. Cancer Research Centers
    3. Clinics
  5. By Region
    1. North America
    2. Latin America
    3. Europe
    4. Middle East and Africa
    5. Asia-Pacific
  6. By Company
    1. Revenue Shares
    2. Strategic Factorial Indexing
    3. Competitor Placement in MarkNtel Quadrant
North America Cancer Immunotherapy Market Analysis, 2020- 2030F
1. Market Size & Analysis
  1. Market Revenue
2. Market Share & Analysis
  1. By Product Type
  2. By Cancer Type
  3. By End User
  4. By Mechanism of Actions
  5. By Country
    1. United States
    2. Canada
3. United States Cancer Immunotherapy Market Analysis, 2020- 2030F
  1. Market Size & Analysis
    1. Market Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By Cancer Type
    3. By End User
    4. By Mechanism of Actions
4. Canada Cancer Immunotherapy Market Analysis, 2020- 2030F
  1. Market Size & Analysis
    1. Market Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By Cancer Type
    3. By End User
    4. By Mechanism of Actions
Latin America Cancer Immunotherapy Market Analysis, 2020- 2030F
1. Market Size & Analysis
  1. Market Revenue
2. Market Share & Analysis
  1. By Product Type
  2. By Cancer Type
  3. By Mechanism of Actions
  4. By End User
  5. By Country
    1. Brazil
    2. Argentina
    3. Mexico
3. Brazil Cancer Immunotherapy Market Analysis, 2020- 2030F
  1. Market Size & Analysis
    1. Market Revenue
  2. Market Share & Analysis
  3. By Product Type
  4. By Cancer Type
  5. By Mechanism of Actions
  6. By End User
4. Argentina Cancer Immunotherapy Market Analysis, 2020- 2030F
  1. Market Size & Analysis
    1. Market Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By Cancer Type
    3. By Mechanism of Actions
    4. By End User
5. Mexico Cancer Immunotherapy Market Analysis, 2020- 2030F
  1. Market Size & Analysis
    1. Market Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By Cancer Type
    3. By Mechanism of Actions
    4. By End User
Europe Cancer Immunotherapy Market Analysis, 2020- 2030F
1. Market Size & Analysis
  1. Market Revenue
2. Market Share & Analysis
  1. By Product Type
  2. By Cancer Type
  3. By Mechanism of Actions
  4. By End User
  5. By Country
    1. France
    2. Germany
    3. Italy
    4. United Kingdom
    5. Spain
3. France Cancer Immunotherapy Market Analysis, 2020- 2030F
  1. Market Size & Analysis
    1. Market Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By Cancer Type
    3. By Mechanism of Actions
    4. By End User
4. Germany Cancer Immunotherapy Market Analysis, 2020- 2030F
  1. Market Size & Analysis
    1. Market Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By Cancer Type
    3. By Mechanism of Actions
    4. By End User
5. Italy Cancer Immunotherapy Market Analysis, 2020- 2030F
  1. Market Size & Analysis
    1. Market Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By Cancer Type
    3. By Mechanism of Actions
    4. By End User
6. United Kingdom Cancer Immunotherapy Market Analysis, 2020- 2030F
  1. Market Size & Analysis
    1. Market Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By Cancer Type
    3. By Mechanism of Actions
    4. By End User
7. Spain Cancer Immunotherapy Market Analysis, 2020- 2030F
  1. Market Size & Analysis
    1. Market Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By Cancer Type
    3. By Mechanism of Actions
    4. By End User
Middle East and Africa Cancer Immunotherapy Market Analysis, 2020- 2030F
1. Market Size & Analysis
  1. Market Revenue
2. Market Share & Analysis
  1. By Product Type
  2. By Cancer Type
  3. By Mechanism of Actions
  4. By End User
  5. By Country
    1. UAE
    2. Saudi Arabia
    3. Turkey
    4. South Africa
3. UAE Cancer Immunotherapy Market Analysis, 2020- 2030F
  1. Market Size & Analysis
    1. Market Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By Cancer Type
    3. By Mechanism of Actions
    4. By End User
4. Saudi Arabia Cancer Immunotherapy Market Analysis, 2020- 2030F
  1. Market Size & Analysis
    1. Market Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By Cancer Type
    3. By Mechanism of Actions
    4. By End User
5. Turkey Cancer Immunotherapy Market Analysis, 2020- 2030F
  1. Market Size & Analysis
    1. Market Revenue
    2. Units Sold
  2. Market Share & Analysis
    1. By Product Type
    2. By Cancer Type
    3. By Mechanism of Actions
    4. By End User
6. South Africa Cancer Immunotherapy Market Analysis, 2020- 2030F
  1. Market Size & Analysis
    1. Market Revenue
    2. Units Sold
  2. Market Share & Analysis
    1. By Product Type
    2. By Cancer Type
    3. By Mechanism of Actions
    4. By End User
Asia-Pacific Cancer Immunotherapy Market Analysis, 2020- 2030F
1. Market Size & Analysis
  1. Market Revenue
2. Market Share & Analysis
  1. By Product Type
  2. By Cancer Type
  3. By Mechanism of Actions
  4. By End User
  5. By Country
    1. China
    2. India
    3. Japan
    4. Australia
    5. South Korea
3. China Cancer Immunotherapy Market Analysis, 2020- 2030F
  1. Market Size & Analysis
    1. Market Revenue
  2. Market Share & Analysis
  3. By Product Type
  4. By Cancer Type
  5. By Mechanism of Actions
  6. By End User
4. India Cancer Immunotherapy Market Analysis, 2020- 2030F
  1. Market Size & Analysis
    1. Market Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By Cancer Type
    3. By Mechanism of Actions
    4. By End User
5. Japan Cancer Immunotherapy Market Analysis, 2020- 2030F
  1. Market Size & Analysis
    1. Market Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By Cancer Type
    3. By Mechanism of Actions
    4. By End User
6. Australia Cancer Immunotherapy Market Analysis, 2020- 2030F
  1. Market Size & Analysis
    1. Market Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By Cancer Type
    3. By Mechanism of Actions
    4. By End User
7. South Korea Cancer Immunotherapy Market Analysis, 2020- 2030F
  1. Market Size & Analysis
    1. Market Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By Cancer Type
    3. By Mechanism of Actions
    4. By End User
Global Cancer Immunotherapy Market Policies, Regulations, Product Standards
Global Cancer Immunotherapy Market Trends & Insights
Global Cancer Immunotherapy Market Dynamics
1. Growth Drivers
2. Challenges
3. Impact Analysis
Global Cancer Immunotherapy Market Hotspot & Opportunities
Global Cancer Immunotherapy Market Key Strategic Imperatives for Success & Growth
Global Competition Outlook
1. Competition Matrix
  1. Product Portfolio
  2. Brand Specialization
  3. Target Markets
  4. Target Cancer Types
  5. Research & Development
  6. Strategic Alliances
  7. Strategic Initiatives
2. Company Profiles (Business Description, Product Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)
  1. Amgen Inc.,
  2. Astrazeneca,
  3. Bayer AG,
  4. Bristol-Myers Squibb,
  5. ELI Lilly and Company,
  6. Janssen Global Services LLC
  7. Johnson and Johnson),
  8. Merck,
  9. Novartis,
  10. Pfizer, F.
  11. F. Hoffmann-La Roche AG
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO INQUIRE BEFORE BUYING THIS REPORT

Name *

Email ID *

Country *